Abstract
Oral administration (gavage) of a second-generation probiotic, Lactobacillus reuteri (L. reuteri), that releases interleukin-22 (LR-IL-22) at 24 h aft......
小提示:本篇文献需要登录阅读全文,点击跳转登录